共 50 条
Evaluation of ACCEPT to predict COPD exacerbations in NOVELTY
被引:0
|作者:
Lewis, Samuel
[1
]
Taylor, Adam
[1
]
Rapsomaniki, Eleni
[2
]
Mullerova, Hana
[3
]
Kristensson, Cecilia
[4
]
Harper, Andrew
[5
]
Burgel, Pierre-Regis
[6
,7
]
Sadatsafavi, Mohsen
[8
]
Owen, Caroline
[9
]
Hughes, Rod
[10
]
机构:
[1] AstraZeneca, BioPharmaceut R&D, DS&AI, Data Sci & Adv Analyt, Cambridge, England
[2] AstraZeneca, BioPharmaceut Med, Med Evidence, Real World Data Sci, Cambridge, England
[3] AstraZeneca, BioPharmaceut Med, Med & Payer Evidence Strategy Resp & Immunol, Cambridge, England
[4] AstraZeneca, BioPharmaceut R&D, Early Resp & Immunol Early Clin Dev, Gothenburg, Sweden
[5] AstraZeneca, BioPharmaceut R&D, Resp & Immunol, Clin Dev Res & Early Dev, Cambridge, England
[6] Cochin Hosp, Assistance Publ Hop Paris, Dept Resp Med, Paris, France
[7] Univ Paris Cite, Inst Cochin, Paris, France
[8] Univ British Columbia, Fac Pharmaceut Sci, Resp Evaluat Sci Program, Vancouver, BC, Canada
[9] AstraZeneca, Early Clin Dev Resp & Immunol, Gaithersburg, MD USA
[10] AstraZeneca, Clin BioPharmaceut R&D, Res & Early Dev Resp & Immunol, Cambridge, England
[11] NOVELTY Sci Community & NOVELTY Study Investigato, Cambridge, England
关键词:
D O I:
10.1183/13993003.congress-2023.PA3622
中图分类号:
R56 [呼吸系及胸部疾病];
学科分类号:
摘要:
引用
收藏
页数:3
相关论文